mifepristone has been researched along with sulprostone in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (30.56) | 18.7374 |
| 1990's | 19 (52.78) | 18.2507 |
| 2000's | 5 (13.89) | 29.6817 |
| 2010's | 1 (2.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguillaume, CJ; Baulieu, EE; Chemama, L; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Tulandi, T | 1 |
| Debu, E; Dufour, B; Fontan, JE; Majorel, P; Scheller, E; Weber, B | 1 |
| Bernadet, P; Boudjemaa, B; Carrie, D; Delay, M; Genestal, M; Livarek, B | 1 |
| Diochin, P; Frydman, R; Pons, JC; Rais, S | 1 |
| Bautrant, E; Blanc, B; Boubli, L; D'Ercole, C; Eyraud, B; Nadal, F | 1 |
| Fontan, JE; Weber, B | 1 |
| Baulieu, EE; Dubois, C; Renault, M; Rezvani, Y; Silvestre, L; Ulmann, A | 1 |
| Haspels, AA; Vervest, HA | 1 |
| Buckshee, K; Hingorani, V; Kumar, S; Malhotra, U; Saraya, L; Sunesh, K | 1 |
| Maria, B; Stampf, F | 2 |
| Dubois, C; Ulmann, A | 1 |
| Bygdeman, M; Swahn, ML | 3 |
| Bahzad, C; Belsey, EM; Kovacs, L; Prasad, RN; Saraya, L; Shi, YE; Swahn, ML; Van Look, PF; Wyssling, H | 1 |
| Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Qing, SS | 1 |
| Beier, S; Chwalisz, K; Elger, W; Fähnrich, M; Hasan, SH; Henderson, D; Neef, G; Rohde, R | 1 |
| Fougeyrollas, B; Spira, A; Thonneau, P | 1 |
| Fougeyrollas, B; Goepp, A; Hercberg, S; Maria, B; Meyer, L; Poirel, H; Spira, A; Thonneau, P | 1 |
| Winikoff, B | 1 |
| Bygdeman, M; Gemzell-Danielsson, K; Gottlieb, C; Swahn, ML | 1 |
| Silvestre, L; Ulmann, A | 1 |
| Daffos, F; Hohlfeld, P; Jacquemard, F; Menez, D; Mirlesse, V; Werner, H | 1 |
| Forcelledo, ML; Poyser, NL | 1 |
| Courtieu, C; Déchaud, H; Marès, P; Marsollier, C; Tailland, ML | 1 |
| Baird, DT | 1 |
| Ho, PC; Ma, HK | 1 |
| Elstein, M; Macrow, P | 1 |
| Tinelli, A; Tinelli, FG; Tinelli, R | 1 |
| Bruinse, HW; Christiaens, GC; De Heus, R; Graziosi, GC; Mol, BW | 1 |
| Willems, FE | 1 |
| Jansen, NE; Pasker-De Jong, PC; Zondervan, HA | 1 |
| Creemers, JW; Ebbers, S; Lotgering, FK | 1 |
| Hayes, JL; Kapp, N; Lohr, PA; Ngo, TD | 1 |
5 review(s) available for mifepristone and sulprostone
| Article | Year |
|---|---|
Nonsurgical treatment of ectopic pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Administration, Oral; Chorionic Gonadotropin; Danazol; Dinoprostone; Drug Therapy, Combination; Female; Glucose; Humans; Injections, Intralesional; Injections, Intramuscular; Laparoscopy; Methotrexate; Mifepristone; Potassium Chloride; Pregnancy; Pregnancy, Ectopic; Vagina | 1992 |
The use of progesterone antagonists in combination with prostaglandin for termination of pregnancy.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Alprostadil; Cervix Uteri; Clinical Trials as Topic; Dinoprostone; Drug Synergism; Female; Humans; Laminaria; Mifepristone; Misoprostol; Multicenter Studies as Topic; Myometrium; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Second; Progesterone; Randomized Controlled Trials as Topic; Uterine Contraction | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
[Induction of labour: which method to use?].
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Adrenal Cortex Hormones; Alprostadil; Catheterization; Dinoprostone; Estrogens; Female; Humans; Interleukin-8; Labor, Induced; Mifepristone; Oxytocin; Pregnancy; Prostaglandins; Relaxin | 2003 |
Cervical preparation for first trimester surgical abortion.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Cervical Ripening; Dinoprost; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, First | 2010 |
13 trial(s) available for mifepristone and sulprostone
| Article | Year |
|---|---|
Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Alprostadil; Dinoprostone; Drug Evaluation; Female; France; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1992 |
[Voluntary abortion induced by mifepristone-sulprostone combination. Effect of phloroglucinol on the time required for expulsion in multipara women].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Phloroglucinol; Pregnancy; Uterine Contraction | 1992 |
[RU 486 (mifepristone) and therapeutic abortions in the second and third trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Cervix Uteri; Dinoprostone; Drug Therapy, Combination; Female; Humans; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third | 1992 |
[Effects of preinduction by mifepristone on therapeutic abortions of the second and third trimesters induced by intravenous sulprostone].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Administration, Oral; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Premedication | 1992 |
Acetaminophen as a pain enhancer during voluntary interruption of pregnancy with mifepristone and sulprostone.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Acetaminophen; Dinoprostone; Double-Blind Method; Drug Interactions; Female; Humans; Male; Mifepristone; Pain; Pregnancy | 1990 |
An antiprogestin steroid and PGE2 for an early pregnancy termination.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Clinical Trials as Topic; Dinoprostone; Female; Hemoglobins; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Pregnancy; Progesterone | 1989 |
Clinical trials with RU 486 (mifepristone): an update.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Clinical Trials as Topic; Dinoprostone; Female; Humans; Labor, Induced; Mifepristone; Pregnancy; Pregnancy Trimester, Second | 1989 |
Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Adult; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Multicenter Studies as Topic; Progestins; Random Allocation | 1989 |
A comparative analysis of fall in haemoglobin following abortions conducted by mifepristone (600 mg) and vacuum aspiration.
Topics: Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Combinations; Female; Hemoglobins; Humans; Metrorrhagia; Mifepristone; Multivariate Analysis; Pregnancy; Suction; Vacuum | 1995 |
RU486: the French experience.
Topics: Abdominal Pain; Abortion, Induced; Adult; Alprostadil; Contraindications; Dinoprostone; Female; France; Humans; Hypotension; Mifepristone; Misoprostol; Myocardial Infarction; Pilot Projects; Pregnancy; Uterine Hemorrhage | 1994 |
[RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Adult; Clinical Protocols; Dinoprostone; Drug Therapy, Combination; Female; Humans; Middle Aged; Mifepristone; Parity; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Time Factors | 1994 |
Termination of second trimester pregnancy with sulprostone and mifepristone: a randomized double-blind placebo-controlled trial.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Administration, Oral; Adolescent; Adult; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Female; Humans; Injections, Intramuscular; Mifepristone; Pregnancy; Pregnancy Trimester, Second; Prospective Studies; Time Factors | 1993 |
Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy.
Topics: Abortifacient Agents; Abortion, Induced; Adult; Dinoprostone; Drug Therapy, Combination; Female; Humans; Length of Stay; Mifepristone; Misoprostol; Polymers; Pregnancy; Pregnancy Trimester, Second; Prospective Studies | 2008 |
19 other study(ies) available for mifepristone and sulprostone
| Article | Year |
|---|---|
[Cardiocirculatory arrest after administration of combined mifepristone (Mifegyne) and sulprostone (Nalador) for induced abortion. Possible role of coronary vasospasm].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Therapeutic; Coronary Vasospasm; Dinoprostone; Drug Combinations; Electric Countershock; Electrocardiography; Female; Heart; Heart Arrest; Humans; Mifepristone; Pregnancy; Radionuclide Imaging; Risk Factors; Thallium Radioisotopes; Ventricular Fibrillation | 1992 |
Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Drug Evaluation; Female; Humans; Mifepristone; Pregnancy; Retrospective Studies; Time Factors; Uterine Hemorrhage | 1990 |
Preliminary results with the antiprogestational compound RU-486 (mifepristone) for interruption of early pregnancy.
Topics: Abortion, Induced; Binding, Competitive; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dinoprostone; Estradiol; Estrenes; Female; Humans; Hydrocortisone; Mifepristone; Peptide Fragments; Progesterone; Prostaglandins E, Synthetic; Receptors, Glucocorticoid; Receptors, Progesterone | 1985 |
Termination of early pregnancy using mifepristone in combination with prostaglandin analogs.
Topics: 16,16-Dimethylprostaglandin E2; Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adult; Dinoprostone; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1989 |
Termination of early pregnancy with RU 486 (mifepristone) in combination with a prostaglandin analogue (sulprostone).
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Dinoprostone; Drug Combinations; Female; Humans; Mifepristone; Pregnancy; Prognosis; Ultrasonography | 1989 |
[Termination of pregnancy with a mifepristone-sulprostone combination].
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Legal; Dinoprostone; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic | 1987 |
The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin.
Topics: Abortion, Therapeutic; Adult; Dinoprostone; Drug Synergism; Estrenes; Female; Humans; Mifepristone; Myometrium; Oxytocin; Pregnancy; Progestins; Prostaglandins E, Synthetic; Time Factors; Uterine Contraction | 1988 |
Endometrial and myometrial effects of progesterone antagonists in pregnant guinea pigs.
Topics: Abortion, Induced; Animals; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Embryo Implantation; Endometrium; Estrenes; Female; Gonanes; Guinea Pigs; Mifepristone; Myometrium; Pregnancy; Pregnancy, Animal; Progesterone; Prostaglandins E, Synthetic; Prostaglandins F; Uterine Contraction | 1987 |
Studies on the mechanisms of action of progesterone antagonists.
Topics: Abortifacient Agents, Steroidal; Animals; Dinoprostone; Embryo Implantation; Epoprostenol; Estrenes; Female; Guinea Pigs; Labor, Obstetric; Mifepristone; Pregnancy; Progesterone; Prostaglandins E, Synthetic; Uterine Contraction | 1986 |
Progesterone receptor blockage. Effect on uterine contractility and early pregnancy.
Topics: Abortifacient Agents, Nonsteroidal; Abortifacient Agents, Steroidal; Abortion, Induced; Dinoprostone; Drug Evaluation; Estrenes; Female; Humans; Mifepristone; Pregnancy; Prostaglandins E, Synthetic; Receptors, Progesterone; Uterine Contraction | 1985 |
Analysis of 369 abortions conducted by mifepristone (RU486) associated with sulprostone in a French family planning center.
Topics: Abortion, Induced; Adult; Chorionic Gonadotropin; Chorionic Gonadotropin, beta Subunit, Human; Dinoprostone; Female; France; Humans; Mifepristone; Peptide Fragments; Pregnancy; Regression Analysis; Retrospective Studies; Time Factors | 1994 |
"RU 486": a luncheon speech.
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Contraception Behavior; Dinoprostone; Drug Industry; Female; Humans; Mifepristone; Politics; Pregnancy; United States | 1994 |
A comparison of the pregnancy-terminating potencies of three anti-progestins in guinea-pigs, and the effects of sulprostone.
Topics: Abortifacient Agents; Abortifacient Agents, Steroidal; Abortion, Induced; Animals; Dinoprostone; Drug Evaluation, Preclinical; Drug Synergism; Estrenes; Female; Guinea Pigs; Mifepristone; Norpregnadienes; Pregnancy; Pregnenediones; Progestins | 1994 |
[The use of sulprostone (Nalador) in the evacuation of uterine contents. Apropos of 32 cases at the Department of Gynecology, University Hospital Center, Nîmes, over 2 years (a retrospective study)].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Adolescent; Adult; Cicatrix; Contraindications; Dinoprostone; Drug Tolerance; Female; France; Gestational Age; Humans; Hydatidiform Mole; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Mifepristone; Misoprostol; Polyhydramnios; Pregnancy; Retrospective Studies; Time Factors; Uterine Diseases; Uterine Neoplasms | 1993 |
Clinical use of mifepristone (RU 486).
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Alprostadil; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Managing miscarriage medically.
Topics: Abortifacient Agents; Abortifacient Agents, Nonsteroidal; Abortion, Spontaneous; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Pregnancy | 1993 |
Medical management for termination of second and third trimester pregnancies: a comparison of strategies.
Topics: Abortifacient Agents; Abortion, Induced; Dinoprostone; Female; Fetal Death; Fetal Diseases; Humans; Mifepristone; Misoprostol; Pregnancy; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Retrospective Studies; Treatment Outcome | 2004 |
[Pregnancy termination in the second trimester with vaginally administered dinoprostone followed by intravenous sulprostone, for the indication 'foetal congenital defects'; results of a retrospective study].
Topics: Abortifacient Agents, Nonsteroidal; Abortion, Induced; Dinoprostone; Female; Humans; Mifepristone; Misoprostol; Placenta, Retained; Pregnancy | 2004 |
[Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone].
Topics: Abortifacient Agents; Abortion, Induced; Adult; Cohort Studies; Dinoprostone; Female; Fetal Diseases; Humans; Middle Aged; Mifepristone; Misoprostol; Parity; Pregnancy; Pregnancy Trimester, Second; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2009 |